Woodline Partners’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
PCM
DC
TCM
BCM
IAM
Woodline Partners's PGEN Position: Q2 2026 in Review
Woodline Partners increased its Precigen (PGEN) stake by 0.04% in Q2 2026, buying an estimated $2.3K and bringing the position to 1,401,945 shares worth $7.99M. The position accounts for 0.02% of the portfolio, ranked #586.
Woodline Partners first reported a position in PGEN in Q4 2025 and has held it in 3 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- Woodline Partners held 1,401,945 shares of Precigen worth $7.99M as of Q2 2026.
- Woodline Partners bought 533 Precigen shares in Q2 2026, an estimated $2.3K.
- Precigen made up 0.02% of Woodline Partners's portfolio in Q2 2026, its #586 holding.
- Woodline Partners first reported a position in Precigen in Q4 2025 and has held it in 3 quarters since.
- 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.